719
Downloads
17
Episodes
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Episodes
7 days ago
7 days ago
The increasing demand for AI talent in the life sciences industry is presenting a challenge for biopharma HR departments. Companies must compete for skilled workers not only against their competitors but also against tech firms that often offer more attractive compensation packages. Steve Swan, CEO of The Swan Group, sat down with Amar Drawid to discuss the current recruitment landscape for AI talent in the life sciences sector, the challenges companies are encountering, and why the mission of drug developers might give them a competitive advantage over tech companies in appealing to certain candidates.
Thursday Oct 24, 2024
Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t
Thursday Oct 24, 2024
Thursday Oct 24, 2024
Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to target a group of cell surface receptors known as GPCRs. Aikium is developing a new class of therapies known as SeqR proteins that offer an alternative to antibody-based drugs and can bind to intrinsically disordered regions of targeted GPCRs that were previously considered undruggable. Venkatesh Mysore, co-founder and CTO of Aikium, sits down with Amar Drawid to discuss how the company is using AI and synthetic biology to discover SeqR protein therapeutics to treat cancer, auto-immune diseases, and neuro-inflammatory disorders.
Thursday Oct 10, 2024
Unlocking Market Access with AI
Thursday Oct 10, 2024
Thursday Oct 10, 2024
Rick Lloyd, founder and senior healthcare advisor of Range Health Advisors, sits down with Amar Drawid to discuss the intricacies of market access in the pharmaceutical industry, the importance of data analytics and AI in navigating the complexities of pricing and reimbursement, and how real-world evidence may help address the challenges faced by patients and healthcare providers in accessing medications.
Thursday Oct 03, 2024
Ensuring Successful Implementation of AI
Thursday Oct 03, 2024
Thursday Oct 03, 2024
Anastasia Christianson, AI and data analytics senior consultant and strategic advisor to life sciences and healthcare companies, sits down with Amar Drawid to discuss the integration of AI in the pharmaceutical industry, the importance of organizational models, and why its important for teams across an organization to co-create rather than to work in isolation.
Thursday Sep 12, 2024
Tackling the New Bottleneck of Drug Discovery
Thursday Sep 12, 2024
Thursday Sep 12, 2024
Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.
Thursday Aug 22, 2024
Swimming in the Deep End of AI
Thursday Aug 22, 2024
Thursday Aug 22, 2024
Brendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to leverage massive RNA biology datasets to drive the development of new therapies.
Thursday Jul 25, 2024
Using AI to Make Biology Easier to Engineer
Thursday Jul 25, 2024
Thursday Jul 25, 2024
Ankit Gupta, the head of AI and Senior Director of Machine Learning Research for Ginkgo Bioworks sits down with Amar Drawid to discuss bioengineering beyond healthcare, how the company is using generative AI and large language models to accelerate bioengineering, it expects this to revolutionize the field.
Thursday Jun 27, 2024
How AI ls Reshaping the Future of Healthcare
Thursday Jun 27, 2024
Thursday Jun 27, 2024
Subodha Kumar, professor of statistics, operations, and data science and the founding director of the Center for Business Analytics and Disruptive Technologies at Temple University’s Fox School of Business, sits down with Amar Drawid to discuss how AI will improve operational efficiency in healthcare, enable mass customization for patients, and free providers up to focus on high-value decision making.
Dr. Amar Drawid
Dr. Amar Drawid is the host of Life Science D’n’A podcast and currently serves as chief AI and business consulting officer for Agilisium Consulting. For nearly 25 years, he has worked in bioinformatics, data analytics, and AI within the life sciences industry with such companies as Sanofi, Celgene, and Novartis. He holds an M.S. and B.S. in bioinformatics, computer science, and molecular biophysics and biochemistry from Yale University and a Ph.D. in computational biology and molecular biophysics (artificial intelligence/machine learning) from Rutgers University